» Articles » PMID: 20235204

Electronic Medical Records for Discovery Research in Rheumatoid Arthritis

Abstract

Objective: Electronic medical records (EMRs) are a rich data source for discovery research but are underutilized due to the difficulty of extracting highly accurate clinical data. We assessed whether a classification algorithm incorporating narrative EMR data (typed physician notes) more accurately classifies subjects with rheumatoid arthritis (RA) compared with an algorithm using codified EMR data alone.

Methods: Subjects with > or =1 International Classification of Diseases, Ninth Revision RA code (714.xx) or who had anti-cyclic citrullinated peptide (anti-CCP) checked in the EMR of 2 large academic centers were included in an "RA Mart" (n = 29,432). For all 29,432 subjects, we extracted narrative (using natural language processing) and codified RA clinical information. In a training set of 96 RA and 404 non-RA cases from the RA Mart classified by medical record review, we used narrative and codified data to develop classification algorithms using logistic regression. These algorithms were applied to the entire RA Mart. We calculated and compared the positive predictive value (PPV) of these algorithms by reviewing the records of an additional 400 subjects classified as having RA by the algorithms.

Results: A complete algorithm (narrative and codified data) classified RA subjects with a significantly higher PPV of 94% than an algorithm with codified data alone (PPV of 88%). Characteristics of the RA cohort identified by the complete algorithm were comparable to existing RA cohorts (80% women, 63% anti-CCP positive, and 59% positive for erosions).

Conclusion: We demonstrate the ability to utilize complete EMR data to define an RA cohort with a PPV of 94%, which was superior to an algorithm using codified data alone.

Citing Articles

Optimal and Safe Estimation for High-Dimensional Semi-Supervised Learning.

Deng S, Ning Y, Zhao J, Zhang H J Am Stat Assoc. 2025; 119(548):2748-2759.

PMID: 40078670 PMC: 11902906. DOI: 10.1080/01621459.2023.2277409.


Uncovering specific genetic-respiratory disease endotypes for rheumatoid arthritis risk.

Kronzer V, Williamson K, Hayashi K, Atkinson E, Crowson C, Wang X Ann Rheum Dis. 2025; 84(2):221-231.

PMID: 39919896 PMC: 11822224. DOI: 10.1136/ard-2024-226391.


Artificial intelligence as an assistant for studying treatment response in rheumatoid arthritis.

Liao K, Cai T Semin Arthritis Rheum. 2024; 70S:152591.

PMID: 39562277 PMC: 11761357. DOI: 10.1016/j.semarthrit.2024.152591.


Advancing rheumatology with natural language processing: insights and prospects from a systematic review.

Omar M, Naffaa M, Glicksberg B, Reuveni H, Nadkarni G, Klang E Rheumatol Adv Pract. 2024; 8(4):rkae120.

PMID: 39399162 PMC: 11467191. DOI: 10.1093/rap/rkae120.


Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.

Venkat R, Hayashi K, Juge P, McDermott G, Paudel M, Wang X Clin Rheumatol. 2024; 43(8):2453-2466.

PMID: 38898318 PMC: 11646335. DOI: 10.1007/s10067-024-07028-w.


References
1.
Effler P, Ching-Lee M, Bogard A, Ieong M, Nekomoto T, Jernigan D . Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA. 1999; 282(19):1845-50. DOI: 10.1001/jama.282.19.1845. View

2.
Greenberg J, Reed G, Kremer J, Tindall E, Kavanaugh A, Zheng C . Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis. 2009; 69(2):380-6. PMC: 2861900. DOI: 10.1136/ard.2008.089276. View

3.
Losina E, Barrett J, Baron J, Katz J . Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol. 2003; 56(6):515-9. DOI: 10.1016/s0895-4356(03)00056-8. View

4.
Lee D, Schur P . Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis. 2003; 62(9):870-4. PMC: 1754666. DOI: 10.1136/ard.62.9.870. View

5.
Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B . Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004; 63(9):1090-5. PMC: 1755129. DOI: 10.1136/ard.2003.014233. View